3001 - 3010 of 6509 Results
Title
Year
-
OPENTitle: Early postnatal injections of whole vaccines compared to placebo controls: Differential behavioural outcomes in miceJournal Name: Journal of Inorganic BiochemistryPublisher: Elsevier BVVol: 212Issue #:Start Page: 111200End Page: 111200Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jinorgbio.2020.111200Best OA location URL: https://www.sciencedirect.com/science/article/am/pii/S0162013420302282?via%3DihubCitation Count: 5
-
OPENTitle: The Library Derived 4554W Peptide Inhibits Primary Nucleation of α-SynucleinJournal Name: Journal of Molecular BiologyPublisher: Elsevier BVVol: 432Issue #: 24Start Page: 166706End Page: 166706Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jmb.2020.11.005Best OA location URL: https://researchportal.bath.ac.uk/en/publications/fb730497-1b80-42eb-b3a3-b52e364bb049Citation Count: 16
-
OPENTitle: A novel approach to study markers of dopamine signaling in peripheral immune cellsJournal Name: Journal of Immunological MethodsPublisher: Elsevier BVVol: 476Issue #:Start Page: 112686End Page: 112686Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jim.2019.112686Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6939127Citation Count: 23
-
OPENTitle: Dopamine agonist treatment increases sensitivity to gamble outcomes in the hippocampus in de novo Parkinson’s diseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 28Issue #:Start Page: 102362End Page: 102362Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nicl.2020.102362Best OA location URL: https://doi.org/10.1016/j.nicl.2020.102362Citation Count: 2
-
OPENTitle: Estimating brain age based on a uniform healthy population with deep learning and structural magnetic resonance imagingJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 91Issue #:Start Page: 15End Page: 25Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.02.009Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7890463Citation Count: 100
-
OPENTitle: Neural connectivity predicts spreading of alpha-synuclein pathology in fibril-injected mouse models: Involvement of retrograde and anterograde axonal propagationJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 134Issue #:Start Page: 104623End Page: 104623Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2019.104623Best OA location URL: https://www.sciencedirect.com/science/article/pii/S0969996119302980?via%3DihubCitation Count: 104
-
OPENTitle: Cerebrospinal fluid ceruloplasmin levels predict cognitive decline and brain atrophy in people with underlying β-amyloid pathologyJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 139Issue #:Start Page: 104810End Page: 104810Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2020.104810Best OA location URL: https://doi.org/10.1016/j.nbd.2020.104810Citation Count: 38
-
OPENTitle: Artificial intelligence within the interplay between natural and artificial computation: Advances in data science, trends and applicationsJournal Name: NeurocomputingPublisher: Elsevier BVVol: 410Issue #:Start Page: 237End Page: 270Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.neucom.2020.05.078Best OA location URL: https://www.sciencedirect.com/science/article/am/pii/S0925231220309292Citation Count: 301
-
OPENTitle: New transgenic models of Parkinson's disease using genome editing technologyJournal Name: Neurología (English Edition)Publisher: Elsevier BVVol: 35Issue #: 7Start Page: 486End Page: 499Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nrleng.2017.08.006Best OA location URL: https://doi.org/10.1016/j.nrleng.2017.08.006Citation Count: 3
-
OPENTitle: The challenge of developing adenosine A2A antagonists for Parkinson disease: Istradefylline, preladenant, and tozadenantJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 80Issue #:Start Page: S54End Page: S63Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.10.027Best OA location URL: https://doi.org/10.1016/j.parkreldis.2020.10.027Citation Count: 42